Defibrillator use on the rise in the European market

In order for smaller companies to enter the burgeoning defibrillator market, they should forge alliances with businesses that can help them improve sales, distribution and market share, according the San Jose-based market research firm Frost & Sullivan.
 
Frost & Sullivan reported that the European external defibrillators market earned revenue of $296 million in 2006, which is expected to reach $440 million in 2013.
 
The surplus of products bodes well for the market, which will ultimately offer of affordable defibrillators. The reduction in costs will allow smaller companies more opportunities in the competitive environment.
 
“Until recently, wider deployment of defibrillators had been constrained by deficiencies in automated external defibrillators technology, including extensive daily maintenance, technical complexity and high cost,” commented Frost & Sullivan research analyst Janani Narasimhan. “Technological developments have solved these shortcomings and revolutionized the treatment of sudden cardiac arrest.”
 
The research also suggested that by educating this user group, defibrillator companies could expand their scope and experience tremendous growth in the commercial and public access markets.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup